Skip to main content
OpenTrials
Completed

NCT Number: NCT07130591

Efficiency of CogniPlat on Cognitive Functions in Older Adults

Mild cognitive impairment is a common intermediate stage between normal aging and dementia, affecting memory and other cognitive domains in older adults. While pharmacologic treatments lack strong evidence, exercise, cognitive training, and game-based interventions have shown positive effects on cognitive functions. The Cogniplat gaming platform, designed to improve cognitive abilities through personalized, multidisciplinary game exercises, has not yet been clinically evaluated. The present study aims to assess the effectiveness of Cogniplat in enhancing cognitive functions in geriatric individuals.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mild Cognitive Impairment Cognition Disorders Cognitive Dysfunction Mental Disorders Neurocognitive Disorders

Age range

65 year–78 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Izmir Democracy Univercity

Izmir, 35000, Turkey (Türkiye)

About this study

Mild cognitive impairment may occur with physiological aging in geriatric individuals. This describes an intermediate stage from normal cognitive status to dementia. In mild cognitive impairment, there is cognitive impairment in both memory and non-memory domains. Anxiety, depression and other adverse mental health conditions also lead to decreased cognitive functioning. The risk of mild cognitive impairment turning into dementia is quite high. Therefore, diagnosis, follow-up and treatment are important issues. Mild cognitive impairment is common in geriatric populations. Its prevalence increases with age and low education level. The incidence of mild cognitive impairment in geriatric individuals aged 65 years and older is 15-20%.

There is no high quality evidence showing the efficacy of pharmacologic agents in the treatment of mild cognitive impairment. There are also studies showing that exercise and cognitive training have an improving effect on cognitive functions. Cognitive games also have a stimulating effect on memory and communication in these individuals. Game-based education reduces the risk of mild cognitive impairment and depression by stimulating the cerebral cortex and also motivates older adults to participate in treatment. Computer-based cognitive gaming training has been found to have positive effects on attention ability and memory development in this population.

The Cogniplat game platform used in the study is a rehabilitation tool developed to improve the cognitive functions of elderly individuals. Cogniplat is based on a multidisciplinary approach combining theories from neuropsychology, cognitive linguistics and speech therapy. It focuses on improving cognitive functions through different game exercises. In addition, Cogniplat automatically adjusts the difficulty and type of exercises by detecting the cognitive needs of individuals. In the literature, the Cogniplat game platform has been developed, but no studies evaluating its effectiveness have been found. Therefore, the present study was planned to examine the effect of the "Cogniplat" game platform on cognitive functions in geriatric individuals.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • To volunteer to participate in the study
  • To be over 65 years old
  • had a mini-mental test score above 24
  • could use smartphones and tablets
  • To have sufficient reading and writing skills to use the gaming platform
  • To have good cooperation skills and not have a disease causing vision loss

Exclusion criteria

  • Individuals with orthopedic or neurological conditions that prevent the use of a tablet with the upper extremities
  • Individuals who are unable to maintain sitting balance
  • Individuals with hearing loss that may prevent them from hearing information related to the gaming platform

Treatment and study plan

Cogniplat game platform

Other

The Cogniplat gaming platform is designed to improve cognitive function in geriatric individuals, with or without mild cognitive impairment. Participants played the Cogniplat games face-to-face with a physiotherapist twice a week on non-consecutive days for 10 weeks, sessions lasting about 30-45 minutes. Scores from the platform were recorded to evaluate progress.

Other names: CGP

Control Group

Other

Individuals in this group did not participate in any regular play program. Demographic data were recorded. For evaluation purposes, a single session of Cogniplat game platform was applied in the first interview and in the second interview 10 weeks later. Initial and final evaluations were recorded.

Other names: CG

Primary outcomes

  1. Mini-Mental Test

    Time frame: At baseline and 10 week after

    The Mini-Mental Test consists of eleven items under five main headings: orientation, recording memory, attention and calculation, recall and language, and is evaluated on a total of 30 points. A score of 23/24 is accepted as the threshold for the diagnosis of mild dementia in Turkish elderly

  2. Game Platform Scoring

    Time frame: At baseline and 10 week after

    For each game played on the platform, game duration, accuracy and speed variables were recorded on the servers connected to the platform. Individuals in both the study and control groups played a game on the platform, and the score of this game was recorded on the system and used in the analysis.Game duration, accuracy and speed will be aggregated into a single game performance score automatically generated by the platform and recorded for analysis

Sponsors and collaborators

Lead sponsor

Izmir Democracy University

Other

Registry information

Official study title

Investigation of the Efficiency of the Cogniplat Gaming Platform on Cognitive Functions in Geriatric Individuals: a Randomized Controlled Trial

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Aug 19, 2025
Registry last updated
Aug 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.